Glioma surgical innovation — fluorescence-guided surgery, intraoperative MRI, awake craniotomy, robotic neurosurgery, and laser interstitial thermal therapy — create the surgical technology market within glioma treatment, with the US Glioma Diagnosis Treatment Market reflecting surgical technology as a commercially important market component.

5-ALA fluorescence-guided surgery (Gleolan, NX Development) — the FDA-approved oral prodrug selectively accumulating in glioma cells as fluorescent protoporphyrin IX — has transformed GBM resection by providing real-time tumor visualization under blue-violet light. The STUPS trial demonstrating sixty-five percent complete resection rate with 5-ALA versus thirty-six percent with white light surgery creating the evidence that drove FDA approval. The survival benefit from maximal safe resection (extent of resection correlating with GBM prognosis) creating the clinical rationale for fluorescence guidance.

Intraoperative MRI (iMRI) — the MRI suites enabling real-time imaging during surgery to confirm extent of resection before closing — represents the premium institutional investment in GBM surgical quality. iMRI demonstrating residual tumor allowing immediate additional resection has improved extent-of-resection rates at centers deploying this technology. Siemens, Philips, and IMRIS providing the institutional-scale iMRI systems at one to three million dollar capital investments.

Laser Interstitial Thermal Therapy (LITT) — the MRI-guided minimally invasive laser ablation for recurrent GBM in surgically difficult locations — represents the emerging minimally invasive alternative to open resection. Medtronic NeuroBlate and Monteris Medical BrainLab platforms providing the commercial LITT systems increasingly adopted for recurrent GBM and radiation necrosis management.

Do you think 5-ALA fluorescence-guided surgery should become the universal standard for all GBM resections, or do the additional preparation time and specific equipment requirements make universal adoption impractical?

FAQ

What is 5-ALA fluorescence-guided GBM surgery? 5-ALA (Gleolan) oral prodrug taken hours before surgery; metabolized selectively in glioma cells to fluorescent protoporphyrin IX; under blue-violet light, glioma tissue glows pink/red distinguishable from normal brain; significantly improves complete resection rate; FDA approved for high-grade glioma surgery.

What is LITT and when is it used for glioma? Laser Interstitial Thermal Therapy uses MRI-guided stereotactically placed laser fiber delivering thermal ablation; used for: recurrent GBM in eloquent or deep locations, radiation necrosis, and lesions unsuitable for open surgery; NeuroBlate (Medtronic) and BrainLab systems; minimally invasive through small burr hole; real-time MRI thermometry monitoring ablation zone.

#USGlioma #GliomaSurgery #5ALAsurgery #Gleolan #FluorescenceGuidedSurgery #IntraoperativeMRI